Pharmaceutical

Ketamine by NRX Pharmaceuticals for Bipolar Disorder (Manic Depression): Likelihood of Approval

Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression).

Feb 20, 2024 - 18:00
Ketamine is under clinical development by NRX Pharmaceuticals and currently in Phase III for Bipolar Disorder (Manic Depression).
Read the original article

Tags:

Previous Article

NA-921 by Biomed Industries for Fragile X Syndrome: Likelihood of Approval

Next Article

SAR-442970 by Sanofi for Hidradenitis Suppurativa: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump

Listen: Who discovered GLP-1? Plus: BrainStorm at the F...

Sep 28, 2023

Opinion: PEPFAR has been a lifeline in Ukraine. Now it’s under threat

Opinion: PEPFAR has been a lifeline in Ukraine. Now it’...

Dec 1, 2023

Innovations in air filters: How a simple filter solution is key to reducing energy consumption

Innovations in air filters: How a simple filter solutio...

Apr 4, 2023